Small-molecule targeted agents: new choices for the treatment of psoriasis / 中华皮肤科杂志
Chinese Journal of Dermatology
;
(12): 747-751, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-957738
ABSTRACT
With the rapid development of immunology and molecular biology in recent years, great progress has been made in the research on psoriatic pathogenesis, as well as in therapeutic strategies targeting key molecules in the pathogenesis. In addition to biologics, small-molecule targeted agents for psoriasis have also received increasing attention, especially agents targeting phosphodiesterase 4, Janus kinase, and tyrosine kinase 2, etc. An increasing number of small-molecule drug candidates have shown favorable efficacy in clinical studies, and some of them have been approved for clinical application and play a unique role in the treatment of psoriasis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Dermatology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS